Fatal association of mechanical valve thrombosis with dabigatran: A report of two cases

Chest

Volumn 144, Issue 1, 2013, Pages 327-328

  Atar, Shaul ^a,b   Wishniak, Alice ^a   Shturman, Alexander ^a,b   Shtiwi, Sewaed ^c   Brezins, Marc ^a,b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; DABIGATRAN; WARFARIN;

AGED; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CEREBROVASCULAR ACCIDENT; CINEFLUOROGRAPHY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; FLUOROSCOPY; HEART ATRIUM FIBRILLATION; HEMIPARESIS; HUMAN; LUNG EDEMA; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; REOPERATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION;

EID: 84880066505     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2486     Document Type: Article

References (9)

1. Granger CB, Alexander JH, McMurray JJ, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365 (11): 981-992.
2. Patel MR, Mahaffey KW, Garg J, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011; 365 (10): 883-891.
3. Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361 (12): 1139-1151.
4. Stewart RA, Astell H, Young L, White HD. Thrombosis on a mechanical aortic valve whilst anti-coagulated with dabigatran. Heart Lung Circ. 2012; 21 (1): 53-55.
5. Price J, Hynes M, Labinaz M, Ruel M, Boodhwani M. Mechanical valve thrombosis on dabigatran. J Am Coll Cardiol. 2012; 60 (17): 1710-1711.
6. Maegdefessel L, Linde T, Krapiec F, et al. In vitro comparison of dabigatran, unfractionated heparin, and low-molecularweight heparin in preventing thrombus formation on mechanical heart valves. Thromb Res. 2010; 126 (3): e196-e200.
7. McKellar SH, Abel S, Camp CL, Suri RM, Ereth MH, Schaff HV. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves. J Thorac Cardiovasc Surg. 2011; 141 (6): 1410-1416.
8. Kaeberich A, Reindl I, Raaz U, et al. Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study. J Thromb Thrombolysis. 2011; 32 (4): 417-425.
9. Van de Werf F, Brueckmann M, Connolly SJ, et al. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). Am Heart J. 2012; 163 (6): 931-937.